Sensorineural hearing loss associated with vincristine treatment

G. Lugassy, A. Shapira

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


We describe a 64-year-old patient with multiple myeloma who developed a sudden sensorineural hearing loss shortly after receiving chemotherapy with vincristine. Ototoxicity is not a known side effect of this drug. It would be of interest to perform repeated audiograms on patients receiving vincristine, in order to appreciate the actual ototoxicity of this drug.

Original languageEnglish
Pages (from-to)320-321
Number of pages2
Issue number5
StatePublished - 1 Nov 1990
Externally publishedYes


  • Hearing loss
  • Ototoxicity
  • Vincristine

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Sensorineural hearing loss associated with vincristine treatment'. Together they form a unique fingerprint.

Cite this